The Latest Headlines at American Banking and Market News
Head-To-Head Comparison: Comstock Resources (NYSE:CRK) and Occidental Petroleum (NYSE:OXY)
Occidental Petroleum (NYSE:OXY – Get Free Report) and Comstock Resources (NYSE:CRK – Get Free Report) are both oils/energy companies, but which is the better stock? We will compare the two companies based on the strength... More of this article »
Financial Analysis: HashiCorp (NASDAQ:HCP) versus EPAM Systems (NYSE:EPAM)
EPAM Systems (NYSE:EPAM – Get Free Report) and HashiCorp (NASDAQ:HCP – Get Free Report) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength... More of this article »
Trupanion (NASDAQ:TRUP) Shares Gap Up Following Insider Buying Activity
Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) shares gapped up prior to trading on Friday after an insider bought additional shares in the company. The stock had previously closed at $24.87, but opened at $26.59. Trupanion... More of this article »
Brokerages Set Centrica plc (LON:CNA) Price Target at GBX 156.25
Centrica plc (LON:CNA – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated... More of this article »
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $54.33 Average Price Target from Analysts
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One research... More of this article »
Arista Networks (NYSE:ANET) Trading 4.2% Higher on Analyst Upgrade
Arista Networks, Inc. (NYSE:ANET – Get Free Report)’s stock price rose 4.2% on Friday after Barclays raised their price target on the stock from $311.00 to $320.00. Barclays currently has an overweight rating on the stock.... More of this article »
Netflix (NASDAQ:NFLX) Stock Price Down 0.4% Following Insider Selling
Netflix, Inc. (NASDAQ:NFLX – Get Free Report) shares fell 0.4% on Friday after an insider sold shares in the company. The stock traded as low as $608.01 and last traded at $609.94. 1,012,142 shares changed hands during mid-day... More of this article »
JFrog (NASDAQ:FROG) Shares Gap Down After Analyst Downgrade
JFrog Ltd. (NASDAQ:FROG – Get Free Report)’s stock price gapped down before the market opened on Friday after KeyCorp lowered their price target on the stock from $52.00 to $46.00. The stock had previously closed at $40.62,... More of this article »
Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down on Analyst Downgrade
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) gapped down prior to trading on Friday after Citigroup lowered their price target on the stock from $62.00 to $60.00. The stock had previously closed at $42.49,... More of this article »
Synaptics (NASDAQ:SYNA) Shares Gap Down Following Analyst Downgrade
Synaptics Incorporated (NASDAQ:SYNA – Get Free Report)’s share price gapped down prior to trading on Friday after Wells Fargo & Company lowered their price target on the stock from $115.00 to $95.00. The stock had... More of this article »
Uber Technologies (NYSE:UBER) Shares Down 1.1% on Analyst Downgrade
Uber Technologies, Inc. (NYSE:UBER – Get Free Report)’s stock price fell 1.1% during trading on Friday after UBS Group lowered their price target on the stock from $100.00 to $95.00. UBS Group currently has a buy rating... More of this article »
Rigetti Computing (NASDAQ:RGTI) Shares Down 7.8% on Disappointing Earnings
Rigetti Computing, Inc. (NASDAQ:RGTI – Get Free Report) was down 7.8% during mid-day trading on Friday following a weaker than expected earnings announcement. The stock traded as low as $1.16 and last traded at $1.18. Approximately... More of this article »
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the stock from $102.00 to $95.00. Oppenheimer currently has an outperform rating... More of this article »